Skip to main content

Table 1 Summary of the impact of combination therapy, MFT and sequential application on useful therapeutic life and the spread of multi-resistant genotypes assuming drug usage typical in control scenarios

From: Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach

Policy Impact
Sequential application Medium useful therapeutic life
  Low multi-drug resistance
MFT Long useful therapeutic life
  Low multi-drug resistance
Combination therapy Longest useful therapeutic life
  Extreme increase in multi-drug resistance